Magnitude Biosciences has closed a fourth round of investment to accelerate the scaling of its business providing C. elegans research services. A total investment of £500,000 will be made by longstanding investors the North East (ERDF) Innovation Fund Limited Partnership, supported by the European Regional Development Fund and managed by Northstar Ventures, and Saker Capital. […]